From 2023 to 2033, the market for Stereotactic Surgery Devices is expected to grow at a 4.1% CAGR, from US$ 26.34 billion in 2023 to US$ 39.36 billion in 2033.The primary factors driving demand for stereotactic surgery devices are rising demand for minimally invasive operations, increasing cancer prevalence, and tec.